AAV gene therapy atlas
All 15 AAV gene therapies in the registry, joined to their capsid, transgene, the disease areas of their trials and approvals, routes and shared sponsors. Those that share things sit near each other, so the field's clusters show up on their own. Click a dot to see what it connects to; drag to rearrange or pan; zoom with the + and − buttons, Ctrl-scroll or a pinch.
No confirmed trial (0)Early phase 1 / phase 1 (0)Phase 2 (0)Phase 3 (6)Approved (9)
Stage is the furthest a product has got: an approval anywhere, else the highest phase among its confirmed trials. Disease areas come from those trials' conditions and the approvals' indications, grouped. Products whose capsid no source states have no capsid link.
All AAV gene therapies
| Product | Capsid | Stage | Transgenes | Route | Disease area |
|---|---|---|---|---|---|
| alipogene tiparvovec (Glybera) | AAV1 | Approved, since withdrawn | LPL (S447X variant) | intramuscular | Metabolic and lysosomal |
| dalnacogene ponparvovec (BBM-H901, XinJiuning) | Approved | F9 | intravenous | Blood | |
| delandistrogene moxeparvovec (Elevidys, SRP-9001) | AAVrh74 | Approved | micro-dystrophin (DMD) | intravenous | Neuromuscular |
| eladocagene exuparvovec (Kebilidi, PTC-AADC, Upstaza) | AAV2 | Approved | DDC | intracerebral | Brain and nerves |
| etranacogene dezaparvovec (Hemgenix) | AAV5 | Approved | F9 (R338L Padua variant) | intravenous | Blood |
| fidanacogene elaparvovec (Beqvez, Durveqtix) | AAVRh74var | Approved | F9 (R338L Padua variant) | intravenous | Blood |
| onasemnogene abeparvovec (Itvisma, OAV-101, Zolgensma) | AAV9 | Approved | SMN1 | intravenous, intrathecal | Neuromuscular |
| valoctocogene roxaparvovec (Roctavian) | AAV5 | Approved | F8 (B-domain deleted) | intravenous | Blood |
| voretigene neparvovec (Luxturna) | AAV2 | Approved | RPE65 | subretinal | Eye |
| 4D-150 (4D-150) | R100 | Phase 3 | intravitreal | Eye | |
| botaretigene sparoparvovec | AAV5 | Phase 3 | RPGR | subretinal | Eye |
| ixoberogene soroparvovec | AAV.7m8 | Phase 3 | aflibercept | intravitreal | Eye |
| laruparetigene zovaparvovec (AGTC-501) | Phase 3 | RPGR | subretinal | Eye | |
| OCU400 (OCU400) | AAV5 | Phase 3 | NR2E3 | Eye | |
| surabgene lomparvovec (ABBV-RGX-314) | AAV8 | Phase 3 | anti-VEGF Fab (ranibizumab-like) | subretinal, suprachoroidal | Eye |